Narnatumab (IMC-RON8) is a neutralizing human monoclonal antibody that blocks RON binding to its ligand, macrophage-stimulating protein (MSP), with a Kd of 32 pM. Narnatumab can be used for the research of cancer[1].
Molecular Weight:
(145.8 kDa)
Purity:
99.93
CAS Number:
[1188275-92-4]
Target:
c-Met/HGFR,Tyrosinase
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted